VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > JAMA Cardiology Study

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Mar 05, 2021 10:03pm

221 Views

Post# 32735144

RE:RE:RE:RE:RE:JAMA Cardiology Study

I've been away from the board for a couple days...getting caught up. G1945V, are you serious in asking GrahamB a technical question? I have him on iggy so won't see his response, but if he even responds, he'll no doubt try to fake his way through it. Whatever, don't buy into his carp! He owns no VPT, and yet takes time out of his day to "save us" from this terrible company. What a waste of skin this fella is!! He's working for someone, nobody spends that amount of time for free

G1945V wrote: GB, ..... would you agree that if VMS 3.0 can detect Atrial Dysfunction it could very well detect inflammation of the heart muscle (myocarditis) that typically occurs in patients with advanced COVID-19 disease.

jmo
G1945V